Literature DB >> 4050318

High levels of C3c in the cerebrospinal fluid from amyotrophic lateral sclerosis patients.

P Annunziata, N Volpi.   

Abstract

A study of several parameters of the humoral immunity in the serum and the cerebrospinal fluid (CSF) of thirteen Amyotrophic Lateral Sclerosis (ALS) patients was carried out. A significant increase in CSF C3c was shown. This feature was found to be significantly correlated to the CSF albumin/serum albumin ration (r = 0.70; p less than 0.05) and to the total CSF proteins (r = 0.86; p less than 0.01). The possible effect of the blood-brain barrier breakdown on the CSF complement levels was evaluated. On the basis of the recently found biochemical changes in ALS cell membranes it is proposed that the high levels of the CSF C3c may also be due to a defective binding to the lymphocytes C3 receptors.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4050318     DOI: 10.1111/j.1600-0404.1985.tb01548.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  20 in total

Review 1.  Neuroprotection in stroke by complement inhibition and immunoglobulin therapy.

Authors:  T V Arumugam; T M Woodruff; J D Lathia; P K Selvaraj; M P Mattson; S M Taylor
Journal:  Neuroscience       Date:  2008-07-12       Impact factor: 3.590

Review 2.  Let's make microglia great again in neurodegenerative disorders.

Authors:  Marie-Victoire Guillot-Sestier; Terrence Town
Journal:  J Neural Transm (Vienna)       Date:  2017-10-12       Impact factor: 3.575

3.  Complement alterations in the CSF of patients with amyotrophic lateral sclerosis.

Authors:  P Annunziata
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-03       Impact factor: 10.154

4.  Label-Free LC-MS/MS Proteomic Analysis of Cerebrospinal Fluid Identifies Protein/Pathway Alterations and Candidate Biomarkers for Amyotrophic Lateral Sclerosis.

Authors:  Mahlon A Collins; Jiyan An; Brian L Hood; Thomas P Conrads; Robert P Bowser
Journal:  J Proteome Res       Date:  2015-10-08       Impact factor: 4.466

5.  Serum C-Reactive Protein as a Prognostic Biomarker in Amyotrophic Lateral Sclerosis.

Authors:  Christian Lunetta; Andrea Lizio; Eleonora Maestri; Valeria Ada Sansone; Gabriele Mora; Robert G Miller; Stanley H Appel; Adriano Chiò
Journal:  JAMA Neurol       Date:  2017-06-01       Impact factor: 18.302

6.  Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models.

Authors:  Sarah Logan; Thiago Arzua; Scott G Canfield; Emily R Seminary; Samantha L Sison; Allison D Ebert; Xiaowen Bai
Journal:  Compr Physiol       Date:  2019-03-14       Impact factor: 9.090

7.  Combination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALS.

Authors:  Jeban Ganesalingam; Jiyan An; Christopher E Shaw; Gerry Shaw; David Lacomis; Robert Bowser
Journal:  J Neurochem       Date:  2011-03-21       Impact factor: 5.372

Review 8.  Brain metabolism in health, aging, and neurodegeneration.

Authors:  Simonetta Camandola; Mark P Mattson
Journal:  EMBO J       Date:  2017-04-24       Impact factor: 11.598

9.  Evaluation of Peripheral Immune Activation in Amyotrophic Lateral Sclerosis.

Authors:  Mengli Wang; Zhen Liu; Juan Du; Yanchun Yuan; Bin Jiao; Xuewei Zhang; Xuan Hou; Lu Shen; Jifeng Guo; Hong Jiang; Kun Xia; Jianguang Tang; Ruxu Zhang; Beisha Tang; Junling Wang
Journal:  Front Neurol       Date:  2021-06-24       Impact factor: 4.003

10.  Blood-spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis.

Authors:  Ethan A Winkler; Jesse D Sengillo; John S Sullivan; Jenny S Henkel; Stanley H Appel; Berislav V Zlokovic
Journal:  Acta Neuropathol       Date:  2012-09-01       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.